There is always the possibility that pharmaceutical companies opt to register their medicines considerably later in some nations than others. It may be necessary at times to make it available in unlicensed markets outside of clinical trial settings or the conventional commercial route.
They may not prioritize access just owing to a lack of footprint, resources, and regional understanding in a certain zone, especially for rare genetic disorder conditions.
By maximizing access in both licensed and unlicensed areas, Invimeds can be your trusted partner that can optimize reach and profitability. Expert local knowledge supported by regional size and extensive support services for India and the Gulf Cooperation Council nations.
We provide a regulatory-compliant and cost-effective solution for pharmaceutical companies to make medicines available to patients where they are not registered for marketing and outside clinical trial settings. In all these cases, InviMeds can provide patients with quick and secure access to the medicines they need through the Managed Access Program.